Tag: phase II PHAROS trial

Pierre

Pierre Fabre Laboratories receives CHMP positive opinion for Braftovi in combination...

0
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending the approval of Braftovi (encorafenib)...

This function has been disabled for HealthTekPak.

error: Content is protected !!